# A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer

> **NCT02501278** · PHASE2 · WITHDRAWN · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC**

## Conditions studied

- Uterine Cervical Neoplasms

## Interventions

- **BIOLOGICAL:** INO-3112 vaccine
- **RADIATION:** Radiotherapy (Extrernal beam radiotherapy + brachytherapy)
- **DRUG:** Cisplatin chemotherapy

## Key facts

- **NCT ID:** NCT02501278
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-05
- **Primary completion:** 2019-05
- **Final completion:** 2021-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** company (Inovio) is no longer able to support the study
- **Last updated:** 2016-05-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02501278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02501278, "A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02501278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*